1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Modeling Parkinson's disease and treatment complications in rodents : Potentials and pitfalls of the current options
(
- Contribution to journal › Article
- 2017
-
Mark
Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
(
- Contribution to journal › Article
- 2014
-
Mark
Preclinical models of levodopa-induced dyskinesia
2014) p.335-353(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Systemic lipopolysaccharide plus MPTP as a model of dopamine loss and gait instability in C57Bl/6J mice
(
- Contribution to journal › Article
- 2008
-
Mark
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
(
- Contribution to journal › Article